139 related articles for article (PubMed ID: 11933675)
1. Benzo[1,2-c]1,2,5-oxadiazole N-oxide derivatives as potential antitrypanosomal drugs. Structure-activity relationships. Part II.
Aguirre G; Cerecetto H; Di Maio R; González M; Porcal W; Seoane G; Ortega MA; Aldana I; Monge A; Denicola A
Arch Pharm (Weinheim); 2002 Jan; 335(1):15-21. PubMed ID: 11933675
[TBL] [Abstract][Full Text] [Related]
2. 1,2,5-Oxadiazole N-oxide derivatives and related compounds as potential antitrypanosomal drugs: structure-activity relationships.
Cerecetto H; Di Maio R; González M; Risso M; Saenz P; Seoane G; Denicola A; Peluffo G; Quijano C; Olea-Azar C
J Med Chem; 1999 Jun; 42(11):1941-50. PubMed ID: 10354402
[TBL] [Abstract][Full Text] [Related]
3. Benzo[1,2-c]1,2,5-oxadiazole N-oxide derivatives as potential antitrypanosomal drugs. Part 3: Substituents-clustering methodology in the search for new active compounds.
Aguirre G; Boiani L; Cerecetto H; Di Maio R; González M; Porcal W; Denicola A; Möller M; Thomson L; Tórtora V
Bioorg Med Chem; 2005 Dec; 13(23):6324-35. PubMed ID: 16115774
[TBL] [Abstract][Full Text] [Related]
4. Quinoxaline N,N'-dioxide derivatives and related compounds as growth inhibitors of Trypanosoma cruzi. Structure-activity relationships.
Aguirre G; Cerecetto H; Di Maio R; González M; Alfaro ME; Jaso A; Zarranz B; Ortega MA; Aldana I; Monge-Vega A
Bioorg Med Chem Lett; 2004 Jul; 14(14):3835-9. PubMed ID: 15203172
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and cruzain docking of 3-(4-substituted-aryl)-1,2,4-oxadiazole-N-acylhydrazones as anti-Trypanosoma cruzi agents.
dos Santos Filho JM; Leite AC; de Oliveira BG; Moreira DR; Lima MS; Soares MB; Leite LF
Bioorg Med Chem; 2009 Sep; 17(18):6682-91. PubMed ID: 19683450
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of hybrid bioisoster derivatives of N-acylhydrazone and furoxan groups with potential and selective anti-Trypanosoma cruzi activity.
Massarico Serafim RA; Gonçalves JE; de Souza FP; de Melo Loureiro AP; Storpirtis S; Krogh R; Andricopulo AD; Dias LC; Ferreira EI
Eur J Med Chem; 2014 Jul; 82():418-25. PubMed ID: 24929292
[TBL] [Abstract][Full Text] [Related]
7. Furoxan-, alkylnitrate-derivatives and related compounds as anti-trypanosomatid agents: mechanism of action studies.
Boiani L; Aguirre G; González M; Cerecetto H; Chidichimo A; Cazzulo JJ; Bertinaria M; Guglielmo S
Bioorg Med Chem; 2008 Sep; 16(17):7900-7. PubMed ID: 18706821
[TBL] [Abstract][Full Text] [Related]
8. 5-Nitro-2-furfuriliden derivatives as potential anti-Trypanosoma cruzi agents: design, synthesis, bioactivity evaluation, cytotoxicity and exploratory data analysis.
Palace-Berl F; Jorge SD; Pasqualoto KF; Ferreira AK; Maria DA; Zorzi RR; de Sá Bortolozzo L; Lindoso JÂ; Tavares LC
Bioorg Med Chem; 2013 Sep; 21(17):5395-406. PubMed ID: 23816040
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of 1,2,5-oxadiazole N-oxide derivatives as hypoxia-selective cytotoxins.
Monge A; López de Ceráin A; Ezpeleta O; Cerecetto H; Dias E; Di Maio R; González M; Onetto S; Seoane G; Suescun L; Mariezcurrena R
Pharmazie; 1998 Nov; 53(11):758-64. PubMed ID: 9853357
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro antitrypanosomal activity of novel Nifurtimox analogues.
Pozas R; Carballo J; Castro C; Rubio J
Bioorg Med Chem Lett; 2005 Mar; 15(5):1417-21. PubMed ID: 15713399
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of nitro heterocycles analogous to megazol, a trypanocidal lead.
Chauvière G; Bouteille B; Enanga B; de Albuquerque C; Croft SL; Dumas M; Périé J
J Med Chem; 2003 Jan; 46(3):427-40. PubMed ID: 12540242
[TBL] [Abstract][Full Text] [Related]
12. 2H-benzimidazole 1,3-dioxide derivatives: a new family of water-soluble anti-trypanosomatid agents.
Boiani M; Boiani L; Denicola A; Torres de Ortiz S; Serna E; Vera de Bilbao N; Sanabria L; Yaluff G; Nakayama H; Rojas de Arias A; Vega C; Rolan M; Gómez-Barrio A; Cerecetto H; Gonzalez M
J Med Chem; 2006 Jun; 49(11):3215-24. PubMed ID: 16722639
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological evaluation and chemometric analysis of indazole derivatives. 1,2-Disubstituted 5-nitroindazolinones, new prototypes of antichagasic drug.
Vega MC; Rolón M; Montero-Torres A; Fonseca-Berzal C; Escario JA; Gómez-Barrio A; Gálvez J; Marrero-Ponce Y; Arán VJ
Eur J Med Chem; 2012 Dec; 58():214-27. PubMed ID: 23124218
[TBL] [Abstract][Full Text] [Related]
14. Mode of action of nifurtimox and N-oxide-containing heterocycles against Trypanosoma cruzi: is oxidative stress involved?
Boiani M; Piacenza L; Hernández P; Boiani L; Cerecetto H; González M; Denicola A
Biochem Pharmacol; 2010 Jun; 79(12):1736-45. PubMed ID: 20178775
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antichagasic properties of new 1,2,6-thiadiazin-3,5-dione 1,1-dioxides and related compounds.
Di Maio R; Cerecetto H; Seoane G; Ochoa C; Arán VJ; Pérez E; Gómez Barrio A; Muelas S
Arzneimittelforschung; 1999 Sep; 49(9):759-63. PubMed ID: 10514904
[TBL] [Abstract][Full Text] [Related]
16. Pyrimido[1,2-a]quinoxaline 6-oxide and phenazine 5,10-dioxide derivatives and related compounds as growth inhibitors of Trypanosoma cruzi.
Lavaggi ML; Aguirre G; Boiani L; Orelli L; García B; Cerecetto H; González M
Eur J Med Chem; 2008 Aug; 43(8):1737-41. PubMed ID: 18068272
[TBL] [Abstract][Full Text] [Related]
17. Trypanosoma cruzi: activities of lapachol and alpha- and beta-lapachone derivatives against epimastigote and trypomastigote forms.
Salas C; Tapia RA; Ciudad K; Armstrong V; Orellana M; Kemmerling U; Ferreira J; Maya JD; Morello A
Bioorg Med Chem; 2008 Jan; 16(2):668-74. PubMed ID: 18029184
[TBL] [Abstract][Full Text] [Related]
18. 2-Phenylaminonaphthoquinones and related compounds: synthesis, trypanocidal and cytotoxic activities.
Sieveking I; Thomas P; Estévez JC; Quiñones N; Cuéllar MA; Villena J; Espinosa-Bustos C; Fierro A; Tapia RA; Maya JD; López-Muñoz R; Cassels BK; Estévez RJ; Salas CO
Bioorg Med Chem; 2014 Sep; 22(17):4609-20. PubMed ID: 25127463
[TBL] [Abstract][Full Text] [Related]
19. New aryloxy-quinone derivatives with promising activity on Trypanosoma cruzi.
Espinosa-Bustos C; Vázquez K; Varela J; Cerecetto H; Paulino M; Segura R; Pizarro J; Vera B; González M; Zarate AM; Salas CO
Arch Pharm (Weinheim); 2020 Jan; 353(1):e1900213. PubMed ID: 31709599
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationship of new growth inhibitors of Trypanosoma cruzi.
Cinque GM; Szajnman SH; Zhong L; Docampo R; Schvartzapel AJ; Rodriguez JB; Gros EG
J Med Chem; 1998 Apr; 41(9):1540-54. PubMed ID: 9554887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
